• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Significance of nuclear expression of mitochondrial transcription factor mtTFA and elucidation of stress resistance

Research Project

  • PDF
Project/Area Number 23590351
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field General medical chemistry
Research InstitutionUniversity of Occupational and Environmental Health, Japan

Principal Investigator

IZUMI Hiroto  産業医科大学, 産業生態科学研究所, 准教授 (50289576)

Co-Investigator(Renkei-kenkyūsha) SHIMAJIRI Shohei  産業医科大学, 医学部, 准教授 (30320344)
Project Period (FY) 2011 – 2013
KeywordsmtTFA / 遺伝子発現 / 転写因子 / 抗アポトーシス / ストレス耐性
Research Abstract

mtTFA synthesized from TFAM (transcription factor A, mitochondrial) gene translocates to mitochondrion and regulates various gene expressions. In this study, we found that mtTFA was also present in not only mitochondrion but also nucleus, mtTFA regulated anti-apoptotic gene expressions such as BIRC5 (Survivin) and BCL2L1 (BCL-xL) at the transcriptional level, the growth of cancer cells was closely correlated with the expression of mtTFA and the nuclear expression of mtTFA was a poor prognostic factor in serous ovarian cancer. These findings suggest that mtTFA might function as anti-apoptosis through gene expressions. Molecular mtTFA targeted therapy might contribute to cancer treatment.

  • Research Products

    (6 results)

All 2012 2011

All Journal Article (3 results) (of which Peer Reviewed: 3 results) Presentation (3 results)

  • [Journal Article] Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer2012

    • Author(s)
      Nakayama Y, Yamauchi M, Minagawa N, Torigoe T, Izumi H, Kohno K, Yamaguchi K
    • Journal Title

      Oncol Rep

      Volume: 27(5) Pages: 1325-1330

    • DOI

      10.3892/or.2012.1640

    • Peer Reviewed
  • [Journal Article] Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer2012

    • Author(s)
      Kurita T, Izumi H, Kagami S, Kawagoe T, Toki N, Matsuura Y, Hachisuga T, Kohno K
    • Journal Title

      Cancer Sci

      Volume: 103(2) Pages: 239-444

    • DOI

      10.1111/j.1349-7006.2011.02156.x

    • Peer Reviewed
  • [Journal Article]2011

    • Author(s)
      Han B, Izumi H, Yasuniwa Y, Akiyama M, Yamaguchi T, Fujimoto N, Matsumoto T, Wu B, Tanimoto A, Sasaguri Y, Kohno K
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 29;408(1) Pages: 45-51

    • DOI

      10.1016/j.bbrc.2011.03.114

    • Peer Reviewed
  • [Presentation] mtTFA regulates BCL2L1 gene expression and its one of the prognostic factors in serous ovarian cancer2011

    • Author(s)
      Akiyama M, Izumi H, Kurita T, Yamaguchi T, Yasuniwa Y, Hachisuga T, Kohno K
    • Organizer
      第70回日本癌学会学術集会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      20111003-05
  • [Presentation] mtTFAは卵巣漿液性嚢胞腺癌の予後不良分子でBcl-XLの発現を制御する2011

    • Author(s)
      栗田智子, 鏡誠治, 卜部理恵, 川越俊典, 土岐尚之, 松浦祐介, 蜂須賀徹, 和泉弘人, 河野公俊
    • Organizer
      第63回日本産科婦人科学会学術講演会
    • Place of Presentation
      リーガロイヤルホテル大阪および大阪国際会議場(大阪)
    • Year and Date
      20110829-31
  • [Presentation] mtTFAは核でBCL2L1の発現を制御し漿液性卵巣がんにおける予後不良因子である2011

    • Author(s)
      秋山正樹, 和泉弘人, 栗田智子, 山口享宏, 安庭義浩, 河野公俊
    • Organizer
      第15回日本がん分子標的治療学会学術集会
    • Place of Presentation
      ホテル日航東京(東京)
    • Year and Date
      20110622-24

URL: 

Published: 2015-07-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi